Trials / Conditions / Renal Cell Cancer Metastatic

Renal Cell Cancer Metastatic

15 registered clinical trials studyying Renal Cell Cancer Metastatic — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC NCT07197580	Telix Pharmaceuticals (Innovations) Pty Limited	Phase 3
Recruiting	Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma NCT07240610	Zhe Chen	—
Completed	Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma NCT07354282	Spanish Oncology Genito-Urinary Group	—
Terminated	Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Expe NCT06264479	Ourotech, Inc.	—
Recruiting	This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatmen NCT06451497	Zumutor Biologics Inc.	Phase 1
Recruiting	National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) NCT05326620	PROspective Renal Cancer Cohort Foundation	—
Completed	Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-as NCT06648902	Kidney Cancer Research Bureau	Phase 1 / Phase 2
Unknown	A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors NCT04903873	Eutilex	Phase 1 / Phase 2
Completed	Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion. NCT04749602	Kidney Cancer Research Bureau	Phase 2
Active Not Recruiting	A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cel NCT03634540	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Terminated	A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastat NCT03876925	Sunshine Lake Pharma Co., Ltd.	Phase 1 / Phase 2
Unknown	CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma NCT03095040	AnewPharma	Phase 3
Completed	Sunitinib Treatment on Tissue Sodium Accumulation (TSS2) NCT04368546	Charite University, Berlin, Germany	—
Terminated	Interleukin-2 in Metastatic Kidney Cancer NCT01702909	Western Regional Medical Center	Phase 2
Completed	5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lu NCT01658813	Western Regional Medical Center	Phase 2